Legal advisor to MC Groep on the acquisition of Slotervaart Hospital

Acted as legal advisor to MC Groep in connection with the acquisition of a majority interest in Slotervaart Hospital.

MC Groep, a private healthcare group led by former physician Loek Winter, acquired the interest from the heirs of businessman John Schram. The transaction followed a complex shareholder dispute involving the minority shareholder, the heirs and other stakeholders. The existing case page states that the transaction value was understood at the time to be between EUR 25 million and EUR 35 million and that ING and Achmea had extended support for the transaction.

The legal work related to the transaction, the shareholder context and the implementation of the acquisition. Healthcare transactions require careful attention to governance, continuity of care, stakeholder interests, financing conditions, contractual obligations and regulatory considerations.

This transaction illustrates that M&A in the healthcare sector is not only about price and transaction documentation, but also about governance, public sensitivity and execution in a complex operational environment.

Need legal advice on a Dutch M&A transaction?

For questions about acquisitions, sale processes, shareholder structures or transaction documentation in the Netherlands, please contact dirk.dewaard@viottalaw.com.

Deal highlights

Transaction type – Acquisition / healthcare M&A

Client – MC Groep

Target – Slotervaart Hospital

Sector – Healthcare / hospitals

Role – Legal advisor to MC Groep

Transaction value – between EUR 25 million and EUR 35 million.

Legal work – Transaction documentation, shareholder context, governance and implementation support

External links

Dealmaker.nl — MC Groep acquires Slotervaart Hospital

Related expertise

Corporate / M&A
Share purchase agreements
Corporate Governance
Commercial contracts

Involved lawyers.

If you need a legal opinion under Dutch law, please do not hesitate to contact us via
info@viottalaw.com or +31 20 248 06 00.

By VIOTTA.

Recent cases.

By VIOTTA.

More articles.

16 / 09 2026

Legal Due Diligence Readiness for Dutch Startups

A Dutch startup should enter investor due diligence with a reconciled cap table, complete corporate records, a clear IP chain and documented equity arrangements. This article explains which legal issues should be addressed before diligence starts and how Dutch counsel can prepare the company for an efficient financing process.

READ ARTICLE
16 / 09 2026

Dutch Startup Share Options in 2027: Tax Reform, SARs and Investor Implications

The Netherlands is proposing a more favourable tax regime for employee share options at qualifying startups and scale-ups from 2027. For foreign investors and founders, the development also affects option pools, dilution, Dutch BV approvals, SAR structures, due diligence and exit treatment.

READ ARTICLE
15 / 09 2026

Structuring the Purchase Price in Dutch M&A: Value, Price and Exit

Economic value, agreed purchase price and the exit proceeds ultimately received by shareholders are not the same. This article explains how purchase prices in Dutch M&A are structured through locked box and completion accounts mechanisms, vendor loans, deferred consideration, earn-outs and staged equity transfers, and how liquidation preferences and exit waterfalls affect founders and investors in VC-backed Dutch companies.

READ ARTICLE
09 / 09 2026

Valuation Gaps in Dutch M&A

Valuation gaps in Dutch M&A are increasingly solved through transaction structure rather than headline price alone. This article explains how buyers and sellers use earn-outs, vendor loans, deferred consideration, rollover equity, locked box, completion accounts, due diligence and LOI drafting to bridge uncertainty in a selective Dutch mid-market.

READ ARTICLE
31 / 08 2026

Can a VC Investor Block a Dividend Distribution in a Dutch BV?

A VC investor can receive a veto right over dividend distributions in a Dutch BV, but that right must be drafted and exercised within the Dutch governance framework. This article explains investor consent rights, Dutch reasonableness and fairness, the distribution test, the role of the board and the company’s interest.

READ ARTICLE
31 / 08 2026

Exiting a Dutch PE Investment

Exiting a Dutch PE investment can involve a trade sale, secondary buy-out, recapitalization, continuation vehicle, management buy-out or IPO. This article explains exit routes, management rollover, vendor due diligence, W&I insurance, drag-along, governance, disclosure and Dutch notarial closing mechanics.

READ ARTICLE